since ceftriaxone was first reviewed in the journal , further studies have confirmed its broad antibacterial spectrum in vitro and extended its clinical documentation in comparative studies with other widely used drugs in infections of the urinary and lower respiratory tract , meningitis in infants and children , uncomplicated gonorrhoea , perioperative prophylaxis in patients undergoing surgery , and in several other types of infection .
C0021270
infants
C0008059
children